BioCentury | May 30, 2018
Distillery Therapeutics

Neurology

...include identifying and testing additional stabilizers of FAM9B G-quadruplex DNA in humanized models of ATR-X. Medac GmbH...
BioCentury | Jun 1, 2017
Distillery Therapeutics

Infectious disease

...Next steps could include testing the combination therapy in animal models of Gram-negative bacterial infection. Medac GmbH...
BioCentury | Mar 24, 2017
Company News

Cevec Pharmaceuticals, Provecs Medical, Medac deal

...Cevec granted Provecs and Medac non-exclusive licenses to use Cevec's CAP-GT technology which the companies will...
...Germany Medac GmbH , Wedel, Germany Provecs Medical GmbH , Hamburg, Germany Business: Cancer Alicia Parker Cevec Pharmaceuticals GmbH medac GmbH Provecs...
BioCentury | May 25, 2015
Company News

Antares, Medac deal

...Medac Pharma subsidiary and Antares granted royalty-free cross-licenses for the U.S. manufacture and sale of Medac’s...
...to settle a 2014 suit. In February 2014, Antares filed suit against Medac alleging that Medac’s...
...using Antares’ Vibex autoinjector technology(see BioCentury, July 21, 2014). Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Medac GmbH...
BioCentury | Nov 10, 2014
Company News

Medac sales and marketing update

...in 10 dosage strengths all of which have a wholesale acquisition cost (WAC) of $448. Medac...
...as Metoject in at least 23 countries, including Russia, Canada and some countries in Europe. Medac GmbH...
BioCentury | Jul 21, 2014
Clinical News

Rasuvo methotrexate regulatory update

...launch the product in the U.S. by year end, but has not yet finalized pricing. Medac...
...reference data on safety and efficacy from the scientific literature or from previously approved products. Medac...
...Antares Pharma Inc. (NASDAQ:ATRS, Ewing, N.J.). In February, Antares filed suit against Medac alleging that Medac’s...
BioCentury | Feb 3, 2014
Clinical News

MPI-2505 regulatory update

...FDA accepted for review an NDA from Medac for MPI-2505 - an autopen containing subcutaneous injectable...
...treat rheumatoid arthritis, polyarticular-course juvenile RA and psoriasis. Medac declined to disclose the PDUFA date. Medac...
...the product as Metoject in 23 countries, including Russia, Canada and some countries in Europe. Medac GmbH...
BioCentury | Jan 28, 2014
Company News

FDA reviewing Medac's injectable methotrexate

...FDA accepted an NDA from Medac GmbH (Wedel, Germany) for MPI-2505 -- an autopen containing subcutaneous injectable...
...rheumatoid arthritis (RA), polyarticular-course juvenile RA and psoriasis. Medac did not disclose the PDUFA date. Medac...
BioCentury | Nov 18, 2013
Clinical News

Gliolan aminolevulinic acid regulatory update

...to Gliolan in Australia and New Zealand from medac's photonamic GmbH and Co. KG subsidiary. medac...
...in the body, where it is converted by enzymes into fluorescent chemicals, particularly protoporphyrin IX. Medac GmbH...
BioCentury | Oct 21, 2013
Company News

Medac management update

...Business: Cancer, Autoimmune, Diagnostic Hired: Terri Shoemaker, a director, as president and CEO of Medac's Medac...
Items per page:
1 - 10 of 23
BioCentury | May 30, 2018
Distillery Therapeutics

Neurology

...include identifying and testing additional stabilizers of FAM9B G-quadruplex DNA in humanized models of ATR-X. Medac GmbH...
BioCentury | Jun 1, 2017
Distillery Therapeutics

Infectious disease

...Next steps could include testing the combination therapy in animal models of Gram-negative bacterial infection. Medac GmbH...
BioCentury | Mar 24, 2017
Company News

Cevec Pharmaceuticals, Provecs Medical, Medac deal

...Cevec granted Provecs and Medac non-exclusive licenses to use Cevec's CAP-GT technology which the companies will...
...Germany Medac GmbH , Wedel, Germany Provecs Medical GmbH , Hamburg, Germany Business: Cancer Alicia Parker Cevec Pharmaceuticals GmbH medac GmbH Provecs...
BioCentury | May 25, 2015
Company News

Antares, Medac deal

...Medac Pharma subsidiary and Antares granted royalty-free cross-licenses for the U.S. manufacture and sale of Medac’s...
...to settle a 2014 suit. In February 2014, Antares filed suit against Medac alleging that Medac’s...
...using Antares’ Vibex autoinjector technology(see BioCentury, July 21, 2014). Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Medac GmbH...
BioCentury | Nov 10, 2014
Company News

Medac sales and marketing update

...in 10 dosage strengths all of which have a wholesale acquisition cost (WAC) of $448. Medac...
...as Metoject in at least 23 countries, including Russia, Canada and some countries in Europe. Medac GmbH...
BioCentury | Jul 21, 2014
Clinical News

Rasuvo methotrexate regulatory update

...launch the product in the U.S. by year end, but has not yet finalized pricing. Medac...
...reference data on safety and efficacy from the scientific literature or from previously approved products. Medac...
...Antares Pharma Inc. (NASDAQ:ATRS, Ewing, N.J.). In February, Antares filed suit against Medac alleging that Medac’s...
BioCentury | Feb 3, 2014
Clinical News

MPI-2505 regulatory update

...FDA accepted for review an NDA from Medac for MPI-2505 - an autopen containing subcutaneous injectable...
...treat rheumatoid arthritis, polyarticular-course juvenile RA and psoriasis. Medac declined to disclose the PDUFA date. Medac...
...the product as Metoject in 23 countries, including Russia, Canada and some countries in Europe. Medac GmbH...
BioCentury | Jan 28, 2014
Company News

FDA reviewing Medac's injectable methotrexate

...FDA accepted an NDA from Medac GmbH (Wedel, Germany) for MPI-2505 -- an autopen containing subcutaneous injectable...
...rheumatoid arthritis (RA), polyarticular-course juvenile RA and psoriasis. Medac did not disclose the PDUFA date. Medac...
BioCentury | Nov 18, 2013
Clinical News

Gliolan aminolevulinic acid regulatory update

...to Gliolan in Australia and New Zealand from medac's photonamic GmbH and Co. KG subsidiary. medac...
...in the body, where it is converted by enzymes into fluorescent chemicals, particularly protoporphyrin IX. Medac GmbH...
BioCentury | Oct 21, 2013
Company News

Medac management update

...Business: Cancer, Autoimmune, Diagnostic Hired: Terri Shoemaker, a director, as president and CEO of Medac's Medac...
Items per page:
1 - 10 of 23